XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net income (loss) $ (15,042) $ 1,020
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 5,260 5,447
Asset impairment charges 100  
Amortization of deferred finance costs included in interest expense   156
Stock-based compensation 184 568
Provision for doubtful accounts 20 173
Restructuring of certain contractual arrangements 756  
Undistributed proportional share of net loss of equity method investee 1,545 277
Loss on early extinguishment of debt   2,324
Deferred income tax (benefit) provision   363
Gain on sale of majority interest in Isaac Mizrahi brand   (20,608)
Gain on sale of limited partner ownership interest (351)  
Gain on settlement of lease liability (445)  
Changes in operating assets and liabilities:    
Accounts receivable (415) 747
Inventory 1,848 (509)
Prepaid expenses and other current and non-current assets 920 235
Deferred revenue 4,676 199
Accounts payable, accrued expenses, accrued payroll, accrued income taxes payable, and other current liabilities (1,395) (995)
Lease-related assets and liabilities (471) (202)
Other liabilities   (224)
Net cash used in operating activities (2,810) (11,029)
Cash flows from investing activities    
Net proceeds from sale of majority interest in Isaac Mizrahi brand   45,408
Net proceeds from sale of assets 451  
Purchase of property and equipment (87) (241)
Net cash provided by (used in) investing activities 364 45,167
Cash flows from financing activities    
Proceeds from exercise of stock options 27  
Shares repurchased including vested restricted stock in exchange for withholding taxes   (442)
Payment of long-term debt   (29,000)
Payment of prepayment, breakage and other fees associated with early extinguishment of long-term debt   (1,511)
Net cash (used in) provided by financing activities 27 (30,953)
Net (decrease) increase in cash and cash equivalents (2,419) 3,185
Cash and cash equivalents at beginning of period 4,608 5,222
Cash and cash equivalents at end of period 2,189 8,407
Reconciliation to amounts on consolidated balance sheets:    
Cash and cash equivalents 2,189  
Total cash, cash equivalents, and restricted cash 2,189 8,407
Supplemental disclosure of non-cash activities:    
Liability for equity-based bonuses and other equity-based payments   (283)
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest   $ 1,032
Cash paid during the period for income taxes $ 16